×

Treatment of cognitive disorders with (R)-7-chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide and pharmaceutically acceptable salts thereof

  • US 8,569,354 B2
  • Filed: 11/12/2012
  • Issued: 10/29/2013
  • Est. Priority Date: 11/19/2008
  • Status: Expired due to Fees
First Claim
Patent Images

1. A method of improving cognition in α

  • patient suffering from Schizophrenia or Alzheimer'"'"'s disease, comprising;

    administering to said patient a daily dose of 3 mg, 2.70 mg, 2.50 mg, 2.25 mg, 2 mg, 1.75 mg, 1.50 mg, 1.25 mg, 1 mg, 0.7 mg, 0.5 mg, 0.3 mg, or 0.1 mg of (R)-7-chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide, or a pharmaceutically acceptable salt thereof.

View all claims
  • 3 Assignments
Timeline View
Assignment View
    ×
    ×